Firm
Counsel are expecting policies that are favourable to patent owners and say the fear factor over applying for patents may diminish
Tilleke & Gibbins’s Indonesia director explains why the firm’s regional presence is a blessing, the threat posed by new practices, and where she sees opportunities
Jane Møller Nielsen explains why a love for linguistics can help build a successful IP career, and reveals the Pippi Longstocking quote that inspires her
The UK Supreme Court will hear another trademark case in Dairy UK v Oatly, this time centring on the registrability of regulated terminology
Sponsored
Sponsored
-
Sponsored by De Penning & De PenningAnand Barnabas and Anandan S of De Penning & De Penning explain how businesses with a strong technology and R&D focus can use freedom-to-operate searches to mitigate intellectual property infringement risks and target growth through innovation -
Sponsored by Bird & BirdMarijn van der Wal of Bird & Bird says a landmark Unified Patent Court case highlights the potential of expert witnesses to enhance patent litigation and shape procedural practices in Europe
-
Sponsored by Wanhuida Intellectual PropertyJicheng Yang and Jianhui Li of Wanhuida Intellectual Property draw on insights from CNIPA practice in discussing how different drafting approaches to crystal form patent claims impact protection scope and patent validity
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula, Swati Dalal, and Vanshika Oberoi of RNA, Technology and IP Attorneys explore the legal framework, challenges, and enforcement strategies for protecting well-known trademarks in India
-
Sponsored by Tilleke & GibbinsAdirek Siriwattasit of Tilleke & Gibbins says Thailand’s new fast-track patent programme for green technologies offers accelerated examinations at no extra cost to applicants, promotes sustainable innovation, and modernises the country’s intellectual property landscape
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs
